Resurrect Bio is a plant biotech company that will improve the immune system of crop species to revolutionize the agricultural industry.
Resurrect Bio has raised $10.3M in total funding. The most recent round was Series A. The last funding was announced in February 2026.
Resurrect Bio's investors include Future Planet Capital, Pymwymic, AgFunder, UK Innovation & Science Seed Fund, Calculus Capital.
Resurrect Bio is headquartered in London, United Kingdom.
Resurrect Bio is a plant biotech company that will improve the immune system of crop species to revolutionize the agricultural industry.
Resurrect Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Resurrect Bio — Funding & Investors." VCBacked, February 17, 2026, https://www.vcbacked.co/company/resurrect-bio. Accessed August 15, 2026.
VCBacked. (2026). Resurrect Bio — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/resurrect-bio
{{cite web |title=Resurrect Bio — Funding & Investors |url=https://www.vcbacked.co/company/resurrect-bio |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated